Cargando…

Oncologist approaches to communicating uncertain disease status in pediatric cancer: a qualitative study

BACKGROUND: Most patients with cancer and their caregivers desire honest, clear prognostic communication, yet oncologists often disclose prognosis inconsistently. Prognostic communication becomes even more challenging when disease progression is unclear or equivocal. Presently, oncologist approaches...

Descripción completa

Detalles Bibliográficos
Autores principales: Porter, Amy S., Woods, Cameka, Stall, Melanie, Velrajan, Srilakshmi, Baker, Justin N., Mack, Jennifer W., Kaye, Erica C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620648/
https://www.ncbi.nlm.nih.gov/pubmed/36316675
http://dx.doi.org/10.1186/s12885-022-10190-6
_version_ 1784821370873446400
author Porter, Amy S.
Woods, Cameka
Stall, Melanie
Velrajan, Srilakshmi
Baker, Justin N.
Mack, Jennifer W.
Kaye, Erica C.
author_facet Porter, Amy S.
Woods, Cameka
Stall, Melanie
Velrajan, Srilakshmi
Baker, Justin N.
Mack, Jennifer W.
Kaye, Erica C.
author_sort Porter, Amy S.
collection PubMed
description BACKGROUND: Most patients with cancer and their caregivers desire honest, clear prognostic communication, yet oncologists often disclose prognosis inconsistently. Prognostic communication becomes even more challenging when disease progression is unclear or equivocal. Presently, oncologist approaches for discussing uncertain disease findings are poorly understood. METHODS: In this prospective, longitudinal study, we audio-recorded serial disease reevaluation conversations between children with high-risk cancer, their families, and their primary oncologists over 24 months and conducted content analysis at recorded timepoints when oncologists categorized disease progression as equivocal. RESULTS: Of the 265 medical discussions recorded across the illness course for 33 patient-parent dyads, a total of 40 recorded discussions took place at equivocal timepoints, comprising > 500 min of medical dialogue. Prognosis talk encompassed < 3% of dialogue and was absent in nearly half of equivocal discussions (17/40, 42.5%). Curability statements were identified in only two conversations. Inductive content analysis of dialogue revealed four distinct patterns for communicating equivocal disease status: (1) up-front reassurance, (2) softening the message, (3) describing possible disease progression without interpretation, (4) expressing uncertainty without discussing the bigger picture. CONCLUSION: Oncologists rarely discuss prognosis with children with high-risk cancer and their families at timepoints when disease progression is not definitive. Formal guidance is needed to better support oncologists in navigating uncertainty while sharing honest, person- and family-centered information about prognosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10190-6.
format Online
Article
Text
id pubmed-9620648
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96206482022-11-01 Oncologist approaches to communicating uncertain disease status in pediatric cancer: a qualitative study Porter, Amy S. Woods, Cameka Stall, Melanie Velrajan, Srilakshmi Baker, Justin N. Mack, Jennifer W. Kaye, Erica C. BMC Cancer Research BACKGROUND: Most patients with cancer and their caregivers desire honest, clear prognostic communication, yet oncologists often disclose prognosis inconsistently. Prognostic communication becomes even more challenging when disease progression is unclear or equivocal. Presently, oncologist approaches for discussing uncertain disease findings are poorly understood. METHODS: In this prospective, longitudinal study, we audio-recorded serial disease reevaluation conversations between children with high-risk cancer, their families, and their primary oncologists over 24 months and conducted content analysis at recorded timepoints when oncologists categorized disease progression as equivocal. RESULTS: Of the 265 medical discussions recorded across the illness course for 33 patient-parent dyads, a total of 40 recorded discussions took place at equivocal timepoints, comprising > 500 min of medical dialogue. Prognosis talk encompassed < 3% of dialogue and was absent in nearly half of equivocal discussions (17/40, 42.5%). Curability statements were identified in only two conversations. Inductive content analysis of dialogue revealed four distinct patterns for communicating equivocal disease status: (1) up-front reassurance, (2) softening the message, (3) describing possible disease progression without interpretation, (4) expressing uncertainty without discussing the bigger picture. CONCLUSION: Oncologists rarely discuss prognosis with children with high-risk cancer and their families at timepoints when disease progression is not definitive. Formal guidance is needed to better support oncologists in navigating uncertainty while sharing honest, person- and family-centered information about prognosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10190-6. BioMed Central 2022-10-31 /pmc/articles/PMC9620648/ /pubmed/36316675 http://dx.doi.org/10.1186/s12885-022-10190-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Porter, Amy S.
Woods, Cameka
Stall, Melanie
Velrajan, Srilakshmi
Baker, Justin N.
Mack, Jennifer W.
Kaye, Erica C.
Oncologist approaches to communicating uncertain disease status in pediatric cancer: a qualitative study
title Oncologist approaches to communicating uncertain disease status in pediatric cancer: a qualitative study
title_full Oncologist approaches to communicating uncertain disease status in pediatric cancer: a qualitative study
title_fullStr Oncologist approaches to communicating uncertain disease status in pediatric cancer: a qualitative study
title_full_unstemmed Oncologist approaches to communicating uncertain disease status in pediatric cancer: a qualitative study
title_short Oncologist approaches to communicating uncertain disease status in pediatric cancer: a qualitative study
title_sort oncologist approaches to communicating uncertain disease status in pediatric cancer: a qualitative study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620648/
https://www.ncbi.nlm.nih.gov/pubmed/36316675
http://dx.doi.org/10.1186/s12885-022-10190-6
work_keys_str_mv AT porteramys oncologistapproachestocommunicatinguncertaindiseasestatusinpediatriccanceraqualitativestudy
AT woodscameka oncologistapproachestocommunicatinguncertaindiseasestatusinpediatriccanceraqualitativestudy
AT stallmelanie oncologistapproachestocommunicatinguncertaindiseasestatusinpediatriccanceraqualitativestudy
AT velrajansrilakshmi oncologistapproachestocommunicatinguncertaindiseasestatusinpediatriccanceraqualitativestudy
AT bakerjustinn oncologistapproachestocommunicatinguncertaindiseasestatusinpediatriccanceraqualitativestudy
AT mackjenniferw oncologistapproachestocommunicatinguncertaindiseasestatusinpediatriccanceraqualitativestudy
AT kayeericac oncologistapproachestocommunicatinguncertaindiseasestatusinpediatriccanceraqualitativestudy